Literature DB >> 25810440

An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity.

Yoshimi Tsuda1, Thomas Hoenen2, Logan Banadyga3, Carla Weisend3, Stacy M Ricklefs4, Stephen F Porcella4, Hideki Ebihara3.   

Abstract

Reverse genetics systems represent a key technique for studying replication and pathogenesis of viruses, including Ebola virus (EBOV). During the rescue of recombinant EBOV from Vero cells, a high frequency of mutations was observed throughout the genomes of rescued viruses, including at the RNA editing site of the glycoprotein gene. The influence that such genomic instability could have on downstream uses of rescued virus may be detrimental, and we therefore sought to improve the rescue system. Here we report an improved EBOV rescue system with higher efficiency and genome stability, using a modified full-length EBOV clone in Huh7 cells. Moreover, by evaluating a variety of cells lines, we revealed that EBOV genome instability is cell-type dependent, a fact that has significant implications for the preparation of standard virus stocks. Thus, our improved rescue system will have an impact on both basic and translational research in the filovirus field. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Ebola virus; RNA editing site; mutation; reverse genetics system

Mesh:

Substances:

Year:  2015        PMID: 25810440      PMCID: PMC4564527          DOI: 10.1093/infdis/jiu681

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.

Authors:  V E Volchkov; V A Volchkova; E Muhlberger; L V Kolesnikova; M Weik; O Dolnik; H D Klenk
Journal:  Science       Date:  2001-02-01       Impact factor: 47.728

2.  Inclusion bodies are a site of ebolavirus replication.

Authors:  Thomas Hoenen; Reed S Shabman; Allison Groseth; Astrid Herwig; Michaela Weber; Gordian Schudt; Olga Dolnik; Christopher F Basler; Stephan Becker; Heinz Feldmann
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

3.  Role of VP30 phosphorylation in the Ebola virus replication cycle.

Authors:  Miguel J Martinez; Valentina A Volchkova; Hervé Raoul; Nathalie Alazard-Dany; Olivier Reynard; Viktor E Volchkov
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.

Authors:  Valentina A Volchkova; Olga Dolnik; Miguel J Martinez; Olivier Reynard; Viktor E Volchkov
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Impaired antiviral response in human hepatoma cells.

Authors:  P Keskinen; M Nyqvist; T Sareneva; J Pirhonen; K Melén; I Julkunen
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

6.  A new Ebola virus nonstructural glycoprotein expressed through RNA editing.

Authors:  Masfique Mehedi; Darryl Falzarano; Jochen Seebach; Xiaojie Hu; Michael S Carpenter; Hans-Joachim Schnittler; Heinz Feldmann
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

7.  Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence.

Authors:  H Ebihara; K Yoshimatsu; M Ogino; K Araki; Y Ami; H Kariwa; I Takashima; D Li; J Arikawa
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 8.  Ebola haemorrhagic fever.

Authors:  Heinz Feldmann; Thomas W Geisbert
Journal:  Lancet       Date:  2011-03-05       Impact factor: 79.321

9.  Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection.

Authors:  Jeffrey R Kugelman; Michael S Lee; Cynthia A Rossi; Sarah E McCarthy; Sheli R Radoshitzky; John M Dye; Lisa E Hensley; Anna Honko; Jens H Kuhn; Peter B Jahrling; Travis K Warren; Chris A Whitehouse; Sina Bavari; Gustavo Palacios
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

10.  Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure.

Authors:  Masfique Mehedi; Thomas Hoenen; Shelly Robertson; Stacy Ricklefs; Michael A Dolan; Travis Taylor; Darryl Falzarano; Hideki Ebihara; Stephen F Porcella; Heinz Feldmann
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823

View more
  13 in total

1.  Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.

Authors:  John B Ruedas; Jason T Ladner; Chelsea R Ettinger; Suryaram Gummuluru; Gustavo Palacios; John H Connor
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

2.  Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.

Authors:  John B Ruedas; Catherine E Arnold; Gustavo Palacios; John H Connor
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 3.  Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

Authors:  Logan Banadyga; Michael A Dolan; Hideki Ebihara
Journal:  J Mol Biol       Date:  2016-05-14       Impact factor: 5.469

4.  FAM134B, the Selective Autophagy Receptor for Endoplasmic Reticulum Turnover, Inhibits Replication of Ebola Virus Strains Makona and Mayinga.

Authors:  Abhilash I Chiramel; Jonathan D Dougherty; Vinod Nair; Shelly J Robertson; Sonja M Best
Journal:  J Infect Dis       Date:  2016-08-10       Impact factor: 5.226

5.  Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs.

Authors:  Thomas Hoenen; Andrea Marzi; Dana P Scott; Friederike Feldmann; Julie Callison; David Safronetz; Hideki Ebihara; Heinz Feldmann
Journal:  J Infect Dis       Date:  2015-05-09       Impact factor: 5.226

6.  Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging.

Authors:  Logan Banadyga; Thomas Hoenen; Xavier Ambroggio; Eric Dunham; Allison Groseth; Hideki Ebihara
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

7.  Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory Mice.

Authors:  James Logue; Walter Vargas Licona; Timothy K Cooper; Becky Reeder; Russel Byrum; Jing Qin; Nicole Deiuliis Murphy; Yu Cong; Amanda Bonilla; Jennifer Sword; Wade Weaver; Gregory Kocher; Gene G Olinger; Peter B Jahrling; Lisa E Hensley; Richard S Bennett
Journal:  Viruses       Date:  2019-02-16       Impact factor: 5.048

Review 8.  Filovirus proteins for antiviral drug discovery: A structure/function analysis of surface glycoproteins and virus entry.

Authors:  Baptiste Martin; Thomas Hoenen; Bruno Canard; Etienne Decroly
Journal:  Antiviral Res       Date:  2016-09-14       Impact factor: 5.970

Review 9.  The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development.

Authors:  Wenjun Zhu; Logan Banadyga; Karla Emeterio; Gary Wong; Xiangguo Qiu
Journal:  Viruses       Date:  2019-10-31       Impact factor: 5.048

10.  Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.

Authors:  John C Trefry; Suzanne E Wollen; Farooq Nasar; Joshua D Shamblin; Steven J Kern; Jeremy J Bearss; Michelle A Jefferson; Taylor B Chance; Jeffery R Kugelman; Jason T Ladner; Anna N Honko; Dean J Kobs; Morgan Q S Wending; Carol L Sabourin; William D Pratt; Gustavo F Palacios; M Louise M Pitt
Journal:  Viruses       Date:  2015-12-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.